TriNetX, LLC

Burning feet can be caused by various factors, including:1

Neuropathic Conditions: 12345

• Peripheral neuropathy (damage to nerves in the feet)
• Morton's neuroma (thickening of a nerve between the toes)
• Tarsal tunnel syndrome (compression of the nerve behind the ankle)

Circulatory Problems:1

• Poor circulation (due to arteriosclerosis, peripheral vascular disease)123
• Raynaud's phenomenon (episodes of numbness, tingling, and burning in the fingers and toes)123

Metabolic Disorders:Diabetes (high blood sugar levels), Hypothyroidism (low thyroid hormone levels), and Vitamin B12 deficiency.

Medications:Certain chemotherapy drugs, Anticonvulsants, and Statins.

Other Causes:

• Foot injuries
• Infections (e.g., athlete's foot)
• Allergies
• Stress
• Tight or ill-fitting shoes
• Exposure to chemicals or heavy metals

Specific Causes in Los Angeles:

• High temperatures and humidity
• Prolonged standing or walking on hard surfaces
• Use of certain types of footwear (e.g., high heels)

Note: If you experience burning in your feet, it is important to consult a healthcare professional to determine the underlying cause and receive appropriate treatment.

Diversity in clinical trials is crucial for ensuring that research findings are applicable to the entire population and for addressing health disparities.Efforts to increase diversity involve addressing barriers to participation and ensuring representation across various demographic groups, including race, ethnicity, gender, age, and socioeconomic status.1234

Why is diversity important in clinical trials?

• Generalizability of findings: Clinical trial results should be applicable to the broader population, not just a subset of it.Ensuring diverse representation helps researchers understand how different groups might respond to a treatment or intervention.1234
• Identifying health disparities: Some conditions and responses to treatments can vary based on demographic factors.Diverse trials can help identify these differences and address health disparities.1234
• Building trust and equity: Involving diverse communities in clinical trials can help build trust and promote equitable access to healthcare.12

Barriers to diversity:

• Mistrust and lack of awareness: Some communities may have historical reasons to distrust research or lack awareness about clinical trials.12
• Access and logistical issues: Transportation, time constraints, and language barriers can limit participation, especially for individuals from underrepresented groups.12
• Socioeconomic factors: Lower socioeconomic status and lack of access to resources can also impact participation.12

Efforts to improve diversity:

• Targeted recruitment and outreach: Tailoring recruitment strategies to specific communities and using culturally appropriate materials can help increase participation.12
• Community engagement: Building partnerships with community leaders and organizations can foster trust and encourage participation.12
• Addressing access barriers: Providing transportation assistance, childcare, and other support can help overcome logistical challenges.12345
• Language and cultural sensitivity: Offering information in multiple languages and respecting cultural norms is crucial for inclusive participation.1
• Financial incentives: Compensation for participation, including travel expenses and time, can help address financial barriers.1
• Regulatory requirements: The Food and Drug Omnibus Reform Act of 2022 (Fedora) requires diversity action plans for clinical trials, promoting greater representation.1

The FDA has also taken steps to address diversity in clinical trials as noted in the AJMC , although some recent actions have raised concerns about the agency's commitment.12

Healthcare data companies specialize in collecting, analyzing, and distributing healthcare information to improve patient care, research, and decision-making.Here are some prominent healthcare data companies:12345

Data Aggregators and Distributors:

• Epic Systems: Provider of electronic health records and healthcare software.1
• IQVIA: Global provider of clinical research, healthcare data, and analytics services.12
• Datavant: Platform for connecting and analyzing healthcare data from various sources.1
• TriNetX: Network of healthcare data that facilitates research and insights.1

Analytics and Insights Companies:1

• Arcadia Solutions: Healthcare data analytics company focusing on population health and risk management.123
• Trella Health: Provider of healthcare data and analytics for home health, hospice, and skilled nursing facilities.1
• Prognos Health: Company specializing in predictive analytics and patient journey insights.1

Research and Development Companies:1

• Flatiron Health: Data science company focused on cancer research and treatment.123
• Ciox Health: Healthcare data exchange platform for clinical research and patient records.1
• Carta Healthcare: AI-powered platform for clinical data analysis and insights.1

Other Notable Companies:1

• H1: Provider of healthcare professional data and insights.1
• National Institutes of Health (NIH): Government agency that collects and distributes healthcare data for research purposes.123

It's important to note that the healthcare data landscape is constantly evolving, with new companies emerging and existing ones expanding their offerings.When selecting a healthcare data company, consider factors such as the type of data they provide, their analytics capabilities, and their compliance with healthcare regulations.123456

Signal management is the ongoing, systematic process of detecting, validating, assessing, and acting on potential safety or data quality risks throughout the lifecycle of a product or clinical trial . It is a critical component of pharmacovigilance (drug safety) and clinical trials, ensuring that new, unexpected, or known risks are identified and managed to protect patient safety.123

Core Components of the Signal Management Process
According to GVP Module IX guidelines (often considered the global standard), signal management comprises six key steps:123

1. Signal Detection: Identifying potential risks using data mining (e.g., disproportionality analysis), spontaneous reports, or literature.
2. Validation: Determining if the evidence is sufficient to justify further investigation (e.g., checking for duplicates, ensuring a causal link).
3. Confirmation: Formal verification that the signal represents a new risk or new aspect of a known risk.
4. Prioritization: Ranking signals based on risk to public health, severity, and urgency.
5. Assessment: Detailed scientific analysis to determine if a causal relationship exists between the product and the event.
6. Recommendation for Action: Taking steps to mitigate risk, such as updating product labels, sending safety communications, or, in extreme cases, suspending a marketing authorization.123456

Signal Management in Different Contexts

• Pharmacovigilance (Drug Safety): Focuses on post-marketing surveillance to monitor for adverse drug reactions (ADRs) and unexpected side effects using data sources like EudraVigilance.
• Clinical Trials: Utilizes Centralized Monitoring (CM) to analyze Key Risk Indicators (KRIs) and patient safety data, allowing for immediate corrective action during trials.
• Veterinary Medicine: Involves the same principles, focusing on adverse events in animals (VeDDRA terms) and benefit-risk balance.
• Traffic Management: Refers to organizing the design, operation, and maintenance of traffic signal systems to optimize flow.123456

Key Trends and Technologies

• Automation & AI: Advanced algorithms are increasingly used to detect signals from huge datasets (big data) and social media, reducing manual effort.
• Real-time Surveillance: Moving away from slow, manual reviews to instantaneous, automated alerting systems (e.g., using Medidata or EVIDEX).
• Regulatory Compliance: Rigorous documentation is required to pass audits, with a focus on ensuring the benefit-risk balance remains favorable.1234

Key Roles and Responsibilities

• Marketing Authorization Holders (MAHs): Pharmaceutical companies must continuously monitor their products.
• Regulatory Authorities (e.g., EMA, FDA, MHRA): Oversee safety and may take action on signals.
• Signal Detection Team: Often includes medical doctors, pharmacists, and epidemiologists.12345